BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36370253)

  • 1. Purinergic signaling: a potential therapeutic target for ischemic stroke.
    Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
    Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
    Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S
    Blood; 2011 Dec; 118(23):6141-52. PubMed ID: 21998208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the CD39-CD73-adenosine pathway in liver disease.
    Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
    J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
    Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the T Cell Response by CD39.
    Takenaka MC; Robson S; Quintana FJ
    Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
    Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
    Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
    Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.
    Muñóz-Godínez R; de Lourdes Mora-García M; Weiss-Steider B; Montesinos-Montesinos JJ; Del Carmen Aguilar-Lemarroy A; García-Rocha R; Hernández-Montes J; Azucena Don-López C; Ávila-Ibarra LR; Torres-Pineda DB; Molina-Castillo G; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
    Mediators Inflamm; 2020; 2020():1678780. PubMed ID: 33488292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes.
    Pasquini S; Vincenzi F; Casetta I; Laudisi M; Merighi S; Gessi S; Borea PA; Varani K
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine signaling: Next checkpoint for gastric cancer immunotherapy?
    Shi L; Yang L; Wu Z; Xu W; Song J; Guan W
    Int Immunopharmacol; 2018 Oct; 63():58-65. PubMed ID: 30075429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1.
    de Lourdes Mora-García M; López-Cisneros S; Gutiérrez-Serrano V; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Sánchez-Peña HI; Ávila-Ibarra LR; Don-López CA; Muñóz-Godínez R; Pineda DBT; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
    Mediators Inflamm; 2019; 2019():4651627. PubMed ID: 31205451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules.
    Fuentes E; Palomo I
    Vascul Pharmacol; 2015 Dec; 75():1-6. PubMed ID: 25989108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes.
    Lunkes GI; Lunkes DS; Morsch VM; Mazzanti CM; Morsch AL; Miron VR; Schetinger MR
    Diabetes Res Clin Pract; 2004 Jul; 65(1):1-6. PubMed ID: 15163471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.
    Bertoni APS; de Campos RP; Tamajusuku ASK; Stefani GP; Braganhol E; Battastini AMO; Wink MR
    Life Sci; 2020 Sep; 256():117862. PubMed ID: 32473244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
    Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
    Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
    De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.